Company: BLRX
Filing Date: 2025-01-07
Form Type: 424B5
Source: 0001178913-25-000045
Chunk: 9

Company: BioLineRx Ltd.
Filing Date: 2025-01-07
Form: 424B5
Chunk 9
---
     | Before investing in our securities, you should carefully read and consider the “Risk Factors” beginning on page S-5 of this prospectus supplement and in the documents we incorporate by                                                           
 reference in this prospectus supplement and the accompanying prospectus.                                                                                                                                                                           |
| Depositary      |     | The Bank of New York Mellon.                                                                                                                                                                                                                       |

Unless otherwise indicated, the number of ordinary shares outstanding prior to and after this offering is based on 1,482,601,990 ordinary shares, represented by 98,840,133 ADSs, outstanding as of January 6, 2025, and excludes:

| • | 424,365,585 ordinary shares, represented by 28,291,039 ADSs, issuable upon the exercise of outstanding warrants, at a weighted average exercise price of $0.065 per share (or $0.98 per ADS); |

| • | 49,414,350 ordinary shares, represented by 3,294,290 ADSs issuable upon exercise of pre-funded warrants to be issued to the investors in this offering, at an exercise price of $0.0001 per ADS; |

| • | 118,678,545 ordinary shares, represented by 7,911,903 ADSs, issuable upon the exercise of outstanding options under our Amended and Restated 2003 Share Incentive Plan, or the Share Incentive Plan, at a weighted average exercise price of 
 $0.11 per share (or $1.65 per ADS);                                                                                                                                                                                                          |

| • | 28,333,215 ordinary shares, represented by 1,888,881 ADSs, issuable upon the vesting of restricted stock units and performance stock units under our Share Incentive Plan, with exercise prices ranging from $0 to $0.03 with respect to 
 ordinary shares and $0 to $0.42 with respect to ADSs;                                                                                                                                                                                    |

| • | 53,100,540 ordinary shares, represented by 3,540,036 ADSs, reserved for future issuance under the Share Incentive Plan; |

| • | 235,018,170 ordinary shares represented by 15,667,878 ADSs issuable upon exercise of pre-funded warrants to be issued to the investors in this offering, at an exercise price of $0.0001 per ADS; |

| • | 750,000,000 ordinary shares represented by 50,000,000 ADSs issuable upon